Metformin and cancer: Quo vadis et cui bono?

Oncotarget · 2016 · PMC5342329 · PMID 27356748

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

In our hands, such onco-biguanide activity increased in a temporal manner, reaching a highly significant >80% inhibition of tumor growth [ 16 , 18 ].

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.